Yoshifumi Naka Selected Research

Heart Transplantation (Grafting, Heart)

1/2022	Deep vein thrombosis and pulmonary embolism after heart transplantation.
1/2021	Cardiac transplantation in adult congenital heart disease with prior sternotomy.
1/2021	Levels of Trimethylamine N-Oxide Remain Elevated Long Term After Left Ventricular Assist Device and Heart Transplantation and Are Independent From Measures of Inflammation and Gut Dysbiosis.
1/2021	Outcomes of Heart Transplantation in Adult Congenital Heart Disease With Prior Intracardiac Repair.
10/2020	United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis.
1/2020	Discontinuing amiodarone treatment prior to heart transplantation lowers incidence of severe primary graft dysfunction.
1/2020	Gut microbial diversity, inflammation, and oxidative stress are associated with tacrolimus dosing requirements early after heart transplantation.
1/2020	Transition of a Large Tertiary Heart Failure Program in Response to the COVID-19 Pandemic: Changes That Will Endure.
1/2019	Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.
12/2018	Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshifumi Naka Research Topics

Disease

109	Heart Failure 10/2022 - 01/2002
34	Infections 12/2022 - 11/2003
31	Cardiogenic Shock 01/2022 - 08/2003
25	Hemorrhage 01/2022 - 01/2002
21	Stroke (Strokes) 06/2022 - 05/2004
20	Thrombosis (Thrombus) 01/2022 - 01/2004
12	Inflammation (Inflammations) 01/2021 - 12/2003
9	Myocardial Infarction 01/2022 - 09/2005
9	Diabetes Mellitus 11/2019 - 07/2005
8	Renal Insufficiency (Renal Failure) 06/2022 - 01/2006
7	Shock 01/2022 - 03/2011
7	Primary Graft Dysfunction 01/2020 - 06/2017
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 03/2003
6	Cardiomyopathies (Cardiomyopathy) 12/2017 - 08/2007
5	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 04/2022 - 02/2016
5	Obesity 01/2022 - 01/2010
4	Endotoxemia 01/2021 - 01/2019
4	Atrial Fibrillation 12/2020 - 10/2015
4	Ventricular Tachycardia 10/2020 - 05/2005
4	Pulmonary Hypertension 01/2020 - 05/2003
4	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2018 - 07/2009
4	Hypoxia (Hypoxemia) 11/2017 - 06/2004
4	Hyperglycemia 11/2005 - 12/2003
3	Ischemia 01/2022 - 04/2002
3	Congenital Heart Defects (Congenital Heart Defect) 01/2021 - 10/2016
3	Mitral Valve Insufficiency (Mitral Regurgitation) 12/2020 - 09/2013
3	Amyloidosis 10/2020 - 07/2005
3	Hemolysis 01/2020 - 01/2016
3	Right Ventricular Dysfunction 12/2018 - 03/2002
3	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 01/2006
3	Cardiac Arrhythmias (Arrythmia) 03/2016 - 08/2012
3	Myocarditis (Carditis) 01/2016 - 05/2006
3	End Stage Liver Disease 07/2015 - 06/2012
3	Liver Diseases (Liver Disease) 07/2015 - 06/2012
3	Disease Progression 01/2014 - 11/2005
3	Insulin Resistance 06/2012 - 01/2012
3	Peripheral Vascular Diseases (Peripheral Vascular Disease) 04/2009 - 07/2005
3	Sepsis (Septicemia) 03/2009 - 05/2003
3	Diabetes Complications 11/2006 - 11/2003
2	Hypertension (High Blood Pressure) 12/2022 - 05/2015
2	Vasoplegia 01/2021 - 01/2018
2	Death (Near-Death Experience) 11/2020 - 01/2018
2	COVID-19 10/2020 - 10/2020
2	Fibrosis (Cirrhosis) 11/2018 - 01/2016
2	Clinical Deterioration 11/2018 - 01/2018
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2018 - 08/2012
2	Pain (Aches) 01/2018 - 10/2016
2	Thrombocytopenia (Thrombopenia) 01/2018 - 11/2014
2	Frailty 01/2018 - 05/2014
2	Pulmonary Edema 05/2017 - 11/2011

Drug/Important Bio-Agent (IBA)

8	CreatinineIBA 12/2022 - 11/2006
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2012
6	Prostaglandins DIBA 01/2020 - 06/2017
5	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 06/2010
5	LigandsIBA 05/2006 - 12/2003
4	Proteins (Proteins, Gene)FDA Link 11/2018 - 12/2003
4	Insulin (Novolin)FDA Link 12/2014 - 01/2012
4	AlbuminsIBA 11/2013 - 11/2005
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 12/2016
3	thiazole-4-carboxamide adenine dinucleotide (TCAD)IBA 12/2020 - 01/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 03/2010
3	Amiodarone (Amiodarona)FDA LinkGeneric 01/2020 - 11/2017
3	BilirubinIBA 12/2017 - 11/2011
3	Urea (Carbamide)FDA LinkGeneric 01/2016 - 02/2014
3	NitrogenIBA 01/2016 - 02/2014
3	Polyurethanes (Polyurethane)IBA 08/2008 - 04/2006
3	Receptor for Advanced Glycation End ProductsIBA 05/2006 - 04/2003
2	Cystatin CIBA 10/2022 - 12/2014
2	AnticoagulantsIBA 01/2022 - 01/2004
2	Serum AlbuminIBA 01/2021 - 07/2013
2	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021 - 01/2019
2	LipopolysaccharidesIBA 01/2020 - 01/2020
2	IsoprostanesIBA 01/2020 - 01/2020
2	AdiponectinIBA 01/2020 - 05/2012
2	MyostatinIBA 11/2018 - 05/2010
2	4-methyl-2,3-secocholestane-2,3-diolIBA 01/2018 - 02/2010
2	CeramidesIBA 05/2017 - 06/2012
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017 - 01/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2016 - 01/2016
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2015 - 06/2010

Therapy/Procedure

162	Heart-Assist Devices 12/2022 - 01/2002
59	Therapeutics 01/2022 - 02/2003
43	Heart Transplantation (Grafting, Heart) 01/2022 - 01/2002
28	Transplantation 01/2022 - 03/2003
18	Extracorporeal Membrane Oxygenation 01/2022 - 08/2010
7	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2018 - 02/2013
6	Cannula 01/2022 - 03/2012
5	Contraindications 10/2021 - 07/2005
5	Sternotomy 01/2021 - 03/2015
4	Patient Readmission 01/2021 - 10/2014
4	Length of Stay 01/2016 - 01/2006
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2014 - 01/2003
3	Palliative Care (Palliative Therapy) 01/2021 - 04/2019
3	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 06/2017 - 07/2009
2	Tracheostomy 06/2022 - 11/2017
2	Erythrocyte Transfusion 01/2022 - 04/2020
2	Continuous Renal Replacement Therapy 01/2022 - 04/2006
2	Membrane Oxygenators (Membrane Oxygenator) 11/2017 - 03/2014
2	Renal Replacement Therapy (Therapies, Renal Replacement) 06/2017 - 12/2016
2	Decompression 05/2017 - 11/2011